Cargando…
Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171359/ https://www.ncbi.nlm.nih.gov/pubmed/35686125 http://dx.doi.org/10.3389/fimmu.2022.924099 |
| _version_ | 1784721648913481728 |
|---|---|
| author | Çuburu, Nicolas Finn, Olivera J. Van Der Burg, Sjoerd H. |
| author_facet | Çuburu, Nicolas Finn, Olivera J. Van Der Burg, Sjoerd H. |
| author_sort | Çuburu, Nicolas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9171359 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91713592022-06-08 Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines Çuburu, Nicolas Finn, Olivera J. Van Der Burg, Sjoerd H. Front Immunol Immunology Frontiers Media S.A. 2022-05-24 /pmc/articles/PMC9171359/ /pubmed/35686125 http://dx.doi.org/10.3389/fimmu.2022.924099 Text en Copyright © 2022 Çuburu, Finn and Van Der Burg https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Çuburu, Nicolas Finn, Olivera J. Van Der Burg, Sjoerd H. Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines |
| title | Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines |
| title_full | Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines |
| title_fullStr | Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines |
| title_full_unstemmed | Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines |
| title_short | Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines |
| title_sort | editorial: cancer prevention: targeting premalignant epithelial neoplasms in the era of cancer immunotherapy and vaccines |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171359/ https://www.ncbi.nlm.nih.gov/pubmed/35686125 http://dx.doi.org/10.3389/fimmu.2022.924099 |
| work_keys_str_mv | AT cuburunicolas editorialcancerpreventiontargetingpremalignantepithelialneoplasmsintheeraofcancerimmunotherapyandvaccines AT finnoliveraj editorialcancerpreventiontargetingpremalignantepithelialneoplasmsintheeraofcancerimmunotherapyandvaccines AT vanderburgsjoerdh editorialcancerpreventiontargetingpremalignantepithelialneoplasmsintheeraofcancerimmunotherapyandvaccines |